Literature DB >> 19933701

Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.

Francesc Calafell1, Laura Almasy, Maria Sabater-Lleal, Alfonso Buil, Carolina Mordillo, Anna Ramírez-Soriano, Martin Sikora, Juan Carlos Souto, John Blangero, Jordi Fontcuberta, José Manuel Soria.   

Abstract

The level of Factor XII (FXII) is an important phenotype that exhibits a high genetic component and is associated with thrombotic disease. In a genome-wide linkage scan, we demonstrated that the F12 gene represents a quantitative trait locus (QTL) that influences FXII levels. The current study investigated the genetic architecture of the F12 gene to locate polymorphism(s) responsible for the variation of FXII levels. Re-sequencing of the F12 gene in 40 unrelated individuals (selected from the tails of normal distribution of FXII levels) identified 26 polymorphisms which were genotyped in 398 individuals belonging to 21 families from the GAIT Project. By a measured genotype association analysis, eight of 26 SNPs showed significant P-values less than 10(-5) (after multiple test correction) with FXII levels. In addition, the Bayesian Quantitative Trait Nucleotide method, which infers those polymorphisms most likely to have a direct influence on the trait under study, provided evidence that only rs1801020 variation accounted for the variance attributed to this QTL. Moreover, we have analyzed the evolutionary processes that produced the variation in F12 gene and concluded that is evolutionarily neutral and that the T allele of the rs1801020 appeared approximately 100 000 years ago and spread to most human populations rising to high frequencies by genetic drift. Our study provides a template for future genetic studies of human quantitative traits, as we move beyond QTL localization to the polymorphisms responsible for the variation of important biomedical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933701      PMCID: PMC2798724          DOI: 10.1093/hmg/ddp517

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Genetic determinants of hemostasis phenotypes in Spanish families.

Authors:  J C Souto; L Almasy; M Borrell; M Garí; E Martínez; J Mateo; W H Stone; J Blangero; J Fontcuberta
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

2.  Mapping multiple genes for quantitative or complex traits.

Authors:  Hsiu-Khuern Tang; David Siegmund
Journal:  Genet Epidemiol       Date:  2002-04       Impact factor: 2.135

3.  Minimum-recombinant haplotyping in pedigrees.

Authors:  Dajun Qian; Lars Beckmann
Journal:  Am J Hum Genet       Date:  2002-04-25       Impact factor: 11.025

4.  Estimate of the mutation rate per nucleotide in humans.

Authors:  M W Nachman; S L Crowell
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

5.  Exploring positional candidate genes: linkage conditional on measured genotype.

Authors:  L Almasy; J Blangero
Journal:  Behav Genet       Date:  2004-03       Impact factor: 2.805

6.  Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study.

Authors:  Francesco Zito; Gordon D O Lowe; Ann Rumley; Alex D McMahon; Steve E Humphries
Journal:  Atherosclerosis       Date:  2002-11       Impact factor: 5.162

7.  A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.

Authors:  José Manuel Soria; Laura Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John Blangero
Journal:  Am J Hum Genet       Date:  2002-01-22       Impact factor: 11.025

8.  Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency.

Authors:  T Kanaji; S Kanaji; K Osaki; M Kuroiwa; M Sakaguchi; K Mihara; Y Niho; T Okamura
Journal:  Thromb Haemost       Date:  2001-12       Impact factor: 5.249

9.  Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion.

Authors:  Claudia Kuhli; Inge Scharrer; Frank Koch; Christian Ohrloff; Lars-Olof Hattenbach
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

10.  Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).

Authors:  J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

View more
  12 in total

1.  Common variants of large effect in F12, KNG1, and HRG are associated with activated partial thromboplastin time.

Authors:  Lorna M Houlihan; Gail Davies; Albert Tenesa; Sarah E Harris; Michelle Luciano; Alan J Gow; Kevin A McGhee; David C Liewald; David J Porteous; John M Starr; Gordon D Lowe; Peter M Visscher; Ian J Deary
Journal:  Am J Hum Genet       Date:  2010-03-18       Impact factor: 11.025

Review 2.  The role of large pedigrees in an era of high-throughput sequencing.

Authors:  Ellen M Wijsman
Journal:  Hum Genet       Date:  2012-06-20       Impact factor: 4.132

3.  A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study.

Authors:  Lu-Chen Weng; Mary Cushman; James S Pankow; Saonli Basu; Eric Boerwinkle; Aaron R Folsom; Weihong Tang
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Genome-wide association reveals that common genetic variation in the kallikrein-kinin system is associated with serum L-arginine levels.

Authors:  Weihua Zhang; Fredrik Jernerén; Benjamin C Lehne; Ming-Huei Chen; Robert N Luben; Carole Johnston; Amany Elshorbagy; Ruben N Eppinga; William R Scott; Elizabeth Adeyeye; James Scott; Rainer H Böger; Kay-Tee Khaw; Pim van der Harst; Nicholas J Wareham; Ramachandran S Vasan; John C Chambers; Helga Refsum; Jaspal S Kooner
Journal:  Thromb Haemost       Date:  2016-09-22       Impact factor: 5.249

5.  Genomewide analysis of inherited variation associated with phosphorylation of PI3K/AKT/mTOR signaling proteins.

Authors:  Janna E Hutz; W Aaron Manning; Michael A Province; Howard L McLeod
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

6.  Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study.

Authors:  Yurong Cheng; Yong Li; Nora Scherer; Franziska Grundner-Culemann; Terho Lehtimäki; Binisha H Mishra; Olli T Raitakari; Matthias Nauck; Kai-Uwe Eckardt; Peggy Sekula; Ulla T Schultheiss
Journal:  PLoS Genet       Date:  2022-04-06       Impact factor: 5.917

7.  Resilience to orthostasis and haemorrhage: A pilot study of common genetic and conditioning mechanisms.

Authors:  Dmitry M Davydov; Renad I Zhdanov; Vladimir G Dvoenosov; Olga A Kravtsova; Elena N Voronina; Maxim L Filipenko
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

8.  Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.

Authors:  Nilima Biswas; Adam X Maihofer; Saiful Anam Mir; Fangwen Rao; Kuixing Zhang; Srikrishna Khandrika; Manjula Mahata; Ryan S Friese; C Makena Hightower; Sushil K Mahata; Dewleen G Baker; Caroline M Nievergelt; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  BMC Med Genet       Date:  2016-03-11       Impact factor: 2.103

9.  Ischemic stroke is associated with the ABO locus: the EuroCLOT study.

Authors:  Frances M K Williams; Angela M Carter; Pirro G Hysi; Gabriela Surdulescu; Dylan Hodgkiss; Nicole Soranzo; Matthew Traylor; Steve Bevan; Martin Dichgans; Peter M W Rothwell; Cathie Sudlow; Martin Farrall; Kaisa Silander; Mari Kaunisto; Peter Wagner; Olli Saarela; Kari Kuulasmaa; Jarmo Virtamo; Veikko Salomaa; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Per-Gunnar Wiklund; M Arfan Ikram; Albert Hofman; Giorgio B Boncoraglio; Eugenio A Parati; Anna Helgadottir; Solveig Gretarsdottir; Unnur Thorsteinsdottir; Gudmar Thorleifsson; Kari Stefansson; Sudha Seshadri; Anita DeStefano; Andreas Gschwendtner; Bruce Psaty; Will Longstreth; Braxton D Mitchell; Yu-Ching Cheng; Robert Clarke; Marco Ferrario; Joshua C Bis; Christopher Levi; John Attia; Elizabeth G Holliday; Rodney J Scott; Myriam Fornage; Pankaj Sharma; Karen L Furie; Jonathan Rosand; Mike Nalls; James Meschia; Thomas H Mosely; Alun Evans; Aarno Palotie; Hugh S Markus; Peter J Grant; Tim D Spector
Journal:  Ann Neurol       Date:  2013-01       Impact factor: 10.422

10.  The prevalence of heterozygous F12 mutations in Chinese population and its relevance to incidents of thrombosis.

Authors:  Xi Wu; Qiulan Ding; Xuefeng Wang; Jing Dai; Wenman Wu
Journal:  BMC Med Genet       Date:  2018-03-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.